Anne Marie Fields
Managing Director of PrecisionAQ
Replay available
Cellectar Biosciences, Inc. (CLRB) Q2 2026 Earnings Call
Cellectar Biosciences, Inc. (NASDAQ: CLRB) Q2 2026 earnings conference call, held 2026-08-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jim Caruso
President and CEO
Chad Kolean
Chief Financial Officer
Jarrod Longcor
Chief Operating Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Cellectar Biosciences, Inc..
Replay transcript excerpt
WEBVTT 00:00:29.583 -- 00:00:32.064 . . . 00:00:51.504 -- 00:00:53.945 . . . . 00:02:32.317 -- 00:02:34.437 . . 00:03:10.603 -- 00:03:13.003 . . . . . 00:05:10.328 -- 00:05:12.568 . . . 00:05:51.091 -- 00:05:53.431 . . . 00:07:50.071 -- 00:07:54.372 Good morning, ladies and gentlemen. Thank you for standing by and welcome. 00:07:54.372 -- 00:07:58.694 At this time, all participants are in listening mode, and following the presentation, 00:07:58.694 -- 00:08:01.762 we will conduct a question and answer session. 00:08:01.762 -- 00:08:05.183 Please be advised that today's call may be recorded. 00:08:05.183 -- 00:08:11.084 I would now like to hand the call over to Anne Marie Fields, Managing Director of PrecisionAQ. 00:08:11.084 -- 00:08:13.244 Please go ahead. 00:08:13.244 -- 00:08:17.885 Thank you, operator. Good morning, and welcome to Selectar Biosciences' second quarter 00:08:17.885 -- 00:08:22.366 2026 financial results and business update conference call. 00:08:22.366 -- 00:08:27.327 Joining us today from Selectar are Jim Caruso, President and CEO, who will provide an 00:08:27.327 -- 00:08:32.315 overview of the company's progress, before turning the call over to Chad Kolean, CFO, 00:08:32.315 -- 00:08:36.616 for a financial review of the quarter. Following this, Jarrod Longcor, Chief Operating 00:08:36.616 -- 00:08:40.418 Officer, will give an update on the company's progress and plans for its promising clinical 00:08:40.418 -- 00:08:43.839 development pipeline of radiopharmaceuticals. 00:08:43.839 -- 00:08:47.740 Selectar issued a press release earlier this morning detailing the content of today's 00:08:47.740 -- 00:08:52.841 call. Copy can be found on the investor page of the Selectar's corporate website. 00:08:52.841 -- 00:08:56.463 I want to remind callers th...